Pharmacokinetics and Pharmacodynamics of Recombinant Human Angiotensin-Converting Enzyme 2 in Healthy Human Subjects

Chymase-Dependent Generation of Angiotensin II from Angiotensin-(1-12) in Human Atrial Tissue

(2011) Sarfaraz Ahmad et al.   PLoS One

Recombinant angiotensin-converting enzyme 2 improves pulmonary blood flow and oxygenation in lipopolysaccharide-induced lung injury in piglets

(2010) Benedikt Treml et al.   CRITICAL CARE MEDICINE

Prevention of Angiotensin II–Mediated Renal Oxidative Stress, Inflammation, and Fibrosis by Angiotensin-Converting Enzyme 2

(2010) JiuChang Zhong et al.   HYPERTENSION

Human Recombinant ACE2 Reduces the Progression of Diabetic Nephropathy

(2009) G. Y. Oudit et al.   DIABETES

Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice

(2009) Christoph H. Österreicher et al.   HEPATOLOGY

Targeting the Degradation of Angiotensin II With Recombinant Angiotensin-Converting Enzyme 2

(2009) Jan Wysocki et al.   HYPERTENSION

Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis

(2008) Fina Lovren et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Angiotensin-(1–7): Pharmacological properties and pharmacotherapeutic perspectives

(2008) Dilek Iusuf et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Potential role of Renin–Angiotensin-system for tumor angiogenesis in receptor negative breast cancer

(2008) D. Herr et al.   GYNECOLOGIC ONCOLOGY